Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.3 USD | +0.11% | -4.42% | -8.47% |
Apr. 17 | Sector Update: Health Care Stocks Mixed Wednesday Afternoon | MT |
Apr. 17 | Celldex Therapeutics Says Patient Enrollment Completed in Chronic Inducible Urticaria Treatment Study; Shares Rise | MT |
Financials (USD)
Sales 2024 * | 3.39M | Sales 2025 * | 3.13M | Capitalization | 2.39B |
---|---|---|---|---|---|
Net income 2024 * | -170M | Net income 2025 * | -203M | EV / Sales 2024 * | 622 x |
Net cash position 2024 * | 285M | Net cash position 2025 * | 372M | EV / Sales 2025 * | 646 x |
P/E ratio 2024 * |
-12.5
x | P/E ratio 2025 * |
-11.2
x | Employees | 160 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.65% |
Latest transcript on Celldex Therapeutics, Inc.
1 day | +0.11% | ||
1 week | -4.42% | ||
Current month | -13.51% | ||
1 month | -11.55% | ||
3 months | -0.74% | ||
6 months | +55.79% | ||
Current year | -8.47% |
Managers | Title | Age | Since |
---|---|---|---|
Tibor Keler
FOU | Founder | 65 | 82-12-31 |
Anthony Marucci
FOU | Founder | 62 | 82-12-31 |
Sam Martin
DFI | Director of Finance/CFO | 53 | 09-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Herbert Conrad
BRD | Director/Board Member | 91 | 08-02-29 |
Cheryl L. Cohen
BRD | Director/Board Member | 58 | 22-06-15 |
Harry H. Penner
BRD | Director/Board Member | 78 | 96-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 2 M€ | -.--% | ||
0.02% | 9 M€ | +6.26% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 36.3 | +0.11% | 324,435 |
24-04-25 | 36.26 | -2.05% | 1,021,746 |
24-04-24 | 37.02 | -1.99% | 394,653 |
24-04-23 | 37.77 | -2.78% | 435,996 |
24-04-22 | 38.85 | +2.29% | 552,455 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.47% | 2.39B | |
+1.51% | 42.59B | |
+8.57% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
-3.12% | 11.7B | |
+6.35% | 11.1B |
- Stock Market
- Equities
- CLDX Stock